Dermatologic Manifestations of Neurilemmoma Workup

  • Author: Grace F Kao, MD; Chief Editor: Dirk M Elston, MD   more...
 
Updated: Jan 12, 2012
 

Laboratory Studies

  • Microscopic examination of the tumor biopsy tissue and clinicopathologic correlation establishes the correct diagnosis. The diagnostic microscopic features are described in Histologic Findings.
  • Masson trichrome stain can be used to demonstrate the presence of longitudinal striations observed in smooth muscle tumors to differentiate a cutaneous leiomyoma from a neurilemmoma, which lacks striations.
  • Immunostaining using anti–S-100 protein antibody confirms the presence of Schwann cells.
Next

Imaging Studies

  • With routine radiographic examination, neurilemmomas generally appear as sharply circumscribed tumor masses.
  • CT scan images show circumscribed, low-attenuation masses with uniform or heterogeneous contrast enhancement.
  • MRI reveals a high T2 signal and heterogeneous contrast enhancement.
  • Both CT scan images and MRI show that large tumors often have areas of cystic changes. Benign neurilemmomas do not show active irregular invasion of bone, as is observed in malignant peripheral nerve sheath tumors.
Previous
Next

Histologic Findings

The correct diagnosis of neurilemmoma is established by microscopic examination of tumor biopsy tissue.

Gross appearance

In general, neurilemmomas are firm, smooth-surfaced tumors smaller than 10 cm. Most neurilemmomas affect small nerves. The smaller examples are rounded, somewhat elastic in consistency, and milky-white or semitranslucent. The larger tumors are lobulated irregularly and, by virtue of secondary degenerative changes, become partly or mainly cystic with calcification (ie, ancient change). Areas of hemorrhage and opaque creamy-yellow tumorous tissue are observed on the cut surface (see the image below).

A larger neurilemoma (5 cm in diameter) arising frA larger neurilemoma (5 cm in diameter) arising from a peripheral nerve showing irregularly lobulated and secondary degenerative changes, ie, partly cystic with calcification (the so-called ancient change). Hemorrhage and opaque creamy-yellow areas of tumor are also seen on this cut surface.

Some tumors manifest as a firm rubbery nodule with a whorled appearance on the cut surface, resembling smooth muscle tumors of the uterus. The plexiform or multinodular variant, which accounts for approximately 5% of neurilemmomas, may be discernible upon gross examination (see the images below).

Cut surface of an intradermal plexiform (nodular) Cut surface of an intradermal plexiform (nodular) variety of neurilemoma. The plexiform variants of neurilemoma are rare. The area of nodularity is clearly discernible. Courtesy of the Atlas of Tumor Pathology Armed Forces Institute of Pathology Fascicles, Tumors of the Peripheral Nervous System. Used with permission A low-power photomicrograph of a dermal plexiform A low-power photomicrograph of a dermal plexiform neurilemoma showing nodular aggregates of tumor cells and surrounding loose, myxomatous fibrous stroma. Hematoxylin and eosin stain at 50X magnification.

Microscopic appearance

Most tumors are unilocular masses surrounded by a fibrous capsule composed of epineurium and residual nerve fibers. While this capsule is evident in most tumors, those arising in mucosa (eg, nose, nasopharynx), the central nervous system, and viscera often lack a capsule. Intradermal neurilemmomas and the plexiform or multinodular growth pattern similar to a plexiform neurofibroma are rare. Histologically, the characteristic feature of a neurilemmoma is the pattern of alternating Antoni type A and B areas.

Antoni type A areas (as shown in the image) consist of compact, spindle-shaped cells with twisted nuclei, indistinct cytoplasmic borders, and, occasionally, clear intranuclear vacuoles.

Photomicrograph of a neurilemoma from an area withPhotomicrograph of a neurilemoma from an area with a typical Antoni type A pattern. The palisaded benign Schwann cells show nuclear crowding, with cell processes radiating toward the centers of aggregated tumor cells. Inconspicuous loose fibrous stroma is present at the periphery. Hematoxylin and eosin stain at 150X magnification.

The cells are arranged in short bundles or interlacing fascicles with nuclear palisading, whirling of the cells, and Verocay bodies. Verocay bodies are formed by 2 compact rows of well-aligned nuclei and cell processes that are arranged in a roughly oval shape (see the image below). Verocay bodies are more distinctive of schwannomas than the Antoni A and Antoni B patterns, but they are not seen in all schwannomas.

A photomicrograph showing a characteristic VerocayA photomicrograph showing a characteristic Verocay body of a neurilemoma, consisting of tight, discrete aggregates of spindle-shaped, palisaded nuclei with a central fibrillary area, representing collections of cytoplasmic processes of tumorous Schwann cells. Courtesy of the Atlas of Tumor Pathology Armed Forces Institute of Pathology Fascicles, Tumors of the Peripheral Nervous System. Used with permission.

Mitotic figures are rare. S-100 protein, an acidic protein commonly found in the supporting cells of the central and peripheral nervous system, is demonstrated in neurilemmomas, particularly in the Antoni type A areas. Antoni B areas are less cellular and are often disorderly. The spindle or oval cells are arranged haphazardly in the loose matrix with microcystic changes, inflammatory cells, and delicate collagen fibers. Prominent, irregularly spaced blood vessels are present in the stroma. The psammomatous melanotic neurilemmoma (schwannoma) shows, in addition to the above features, melanin deposition and concentric calcified bodies (psammoma bodies).

Schwannomas have been variably observed to be glial fibrillary acid protein (GFAP) and occasionally keratin positive, with antibodies reacting with multiple keratins (pankeratins, keratin cocktail (CK) (AE1/AE3). Both markers highlighted the cellular Antoni A areas, particularly adjacent to the capsule, myxoid or degenerative areas, and perivascularly. In recent studies of a large series of retroperitoneal schwannomas, 84% of the tumors stained positive for both AE1/AE3 and GFAP. However, the tumor cells were negative for specific keratin polypeptides (K). The findings can be attributed to cross reactivity of AE1/AE3 with other intermediate filament proteins, such as GFAP.[12] Schwannomas contain Leu7 and S-100 protein.

Ultrastructural examination of the tumor reveals almost exclusively a single cell type (ie, Schwann cells). They have characteristic thin cell processes that arrange in undulating layers and are continuous from the cell body. The Schwann cell surface is coated with basal lamina composed of electron-dense material measuring approximately 50 nm (see the image).

Transmission electron micrograph of Antoni type A Transmission electron micrograph of Antoni type A tumor tissue consisting of prominent arrays of Schwann cell processes with basement membrane substance coated on their surfaces. Note the centrally located nucleus with vesicular nuclear chromatin. Uranium acetate and lead citrate stain at 15,000X magnification.

The basal lamina lies in stacks between the cells along with typical and long-spacing collagen fibrils with a 130-nm periodicity. These collagen fibrils are often referred to as a Luse body (see the image).

A transmission electron micrograph of a Luse body,A transmission electron micrograph of a Luse body, ie, typical collagen fibrils and adjacent basement substance. Note the long-spaced, 130-nm periodicity. Uranium acetate and lead citrate stain at 52,500X magnification. Courtesy of the Atlas of Tumor Pathology Armed Forces Institute of Pathology Fascicles, Tumors of the Peripheral Nervous System. Used with permission.

The cytoplasm contains a flattened and sometimes invaginated nucleus, microfibrils, rare lysosomes, and scattered mitochondria. In Antoni B areas, the Schwann cells have increased numbers of lysosomes and myelin figures and fragmented basal lamina.

Immunohistochemical staining using anti–S-100 protein antibody demonstrates uniformly and intensely positive staining of Schwann cells in the tumor (see the image).

A photomicrograph of a dermal neurilemoma with antA photomicrograph of a dermal neurilemoma with anti–S-100 protein immunostaining. The tumorous Schwann cells exhibit uniformly positive staining. Immunoperoxidase stain at 150X magnification.

This technique serves as an important diagnostic tool, and, in severely degenerated neurilemmomas, S-100 protein stain is most valuable for confirming the diagnosis.

The results of immunostaining for myelin proteins used to identify benign and malignant Schwann cell tumors have been variable.

Histologic differential diagnosis

  • Neurofibroma: The loose, myxomatous Antoni type B tissue of a neurilemmoma may mimic a neurofibroma. However, neurofibromas lack the thick collagenous capsule of neurilemmomas and instead are surrounded by a variably thickened perineurium and epineurium. Neurofibromas also lack the Antoni type A and B patterns and Verocay bodies typical of neurilemmomas. Neurofibromas are composed of a mucinous matrix containing scattered, myelinated, and nonmyelinated axons along with a heterogeneous cell population including Schwann cells, fibroblasts, and perineural cells. Consequently, immunoreactivity for S-100 protein is observed in only a portion of the cells comprising a neurofibroma, as opposed to uniform reactivity throughout a neurilemmoma.
  • Palisaded encapsulated neuroma: This is an uncommon, generally solitary, asymptomatic intraneural neuroma that may arise in early childhood or adulthood. It appears as a firm, rubbery, skin-colored or pink papule commonly affecting the "butterfly area" of the face. Palisaded encapsulated neuromas are bulbous expansions of a peripheral nerve. They appear as well-circumscribed, ovoid, or rounded nodules in the dermis, which, in contrast to neurilemmomas, contain a greater number of axons and Schwann cells in interlacing fascicles along with characteristic cleftlike spaces.
  • Schwannoma: These are distinguished from astrocytoma and ependymoma by their abundant parenchymal reticulin, which is positive for type IV collagen. Schwannomas have characteristic contiguous basement membranes along the exterior surfaces of their cells. Although occasionally focal positive staining for GFAP may be present, negative GFAP staining supports the diagnosis of schwannoma. Astrocytomas are generally GFAP positive.
  • Fibrous meningiomas: These lack typical meningeal whorls and psammoma bodies, and they can be difficult to differentiate from schwannomas. EMA is a useful immunomarker for distinguishing the 2 tumors. Meningiomas are reactive with EMA, while schwannomas are not. GFAP can sometimes be used, because some schwannomas are positive but meningiomas are negative.
  • Cutaneous leiomyoma
    • Leiomyomas are benign smooth muscle tumors. They are not derived from neural tissue and generally lack the thick, hyalinized capsule and vasculature of a neurilemmoma. Palisading resembling Verocay bodies may be observed. The blunt-ended nuclei and densely eosinophilic cytoplasm of smooth muscle cells showing distinct cell borders and perinuclear halos help distinguish them from Schwann cells (with their more tapered, spindle-shaped nuclei).
    • Immunohistochemical stains readily distinguish leiomyomas from neurilemmomas, the former staining with myogenic cell markers, such as smooth muscle actin and desmin, and the latter showing positive staining with S-100. Masson trichrome stain may be used to demonstrate the longitudinal striations characteristic of smooth muscle tumors. The ultrastructural features of smooth muscle cells are also highly characteristic, being bounded by a basement membrane and often containing parallel arrays of abundant cytoplasmic microfilaments (actin) with interspersed fusiform dense bodies and pinocytotic vesicles.
  • Palisaded myofibroblastoma: These contain palisaded cells and Verocay bodies that may mimic neurilemmomas. However, palisaded myofibroblastomas involve lymph nodes, contain fibroblastic and myofibroblastic elements, and are negative for S-100 protein staining.
Previous
 
 
Contributor Information and Disclosures
Author

Grace F Kao, MD  Clinical Professor of Dermatopathology, Department of Dermatology, University of Maryland School of Medicine and George Washington University Medical School; Director, Dermatopathology Section, Department of Pathology and Laboratory Medicine, Veterans Affairs Maryland Healthcare System, Baltimore, Maryland

Grace F Kao, MD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, and International Society of Dermatopathology

Disclosure: Nothing to disclose.

Specialty Editor Board

Günter Burg, MD  Professor and Chairman Emeritus, Department of Dermatology, University of Zürich School of Medicine; Delegate of The Foundation for Modern Teaching and Learning in Medicine Faculty of Medicine, University of Zürich, Switzerland

Günter Burg, MD is a member of the following medical societies: American Academy of Dermatology, American Dermatological Association, International Society for Dermatologic Surgery, North American Clinical Dermatologic Society, and Pacific Dermatologic Association

Disclosure: Nothing to disclose.

Michael J Wells, MD  Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center, Paul L Foster School of Medicine

Michael J Wells, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, and Texas Medical Association

Disclosure: Nothing to disclose.

Lester F Libow, MD  Dermatopathologist, South Texas Dermatopathology Laboratory

Lester F Libow, MD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, and Texas Medical Association

Disclosure: Nothing to disclose.

Joel M Gelfand, MD, MSCE  Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania

Joel M Gelfand, MD, MSCE is a member of the following medical societies: Society for Investigative Dermatology

Disclosure: AMGEN Consulting fee Consulting; AMGEN Grant/research funds Investigator; Genentech Grant/research funds investigator; Centocor Consulting fee Consulting; Abbott Grant/research funds investigator; Abbott Consulting fee Consulting; Novartis investigator; Pfizer Grant/research funds investigator; Celgene Consulting fee DMC Chair; NIAMS and NHLBI Grant/research funds investigator

Chief Editor

Dirk M Elston, MD  Director, Ackerman Academy of Dermatopathology, New York

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

References
  1. Humber CC, Copete MA, Hohn FI. Ancient schwannoma of upper lip: case report with distinct histologic features and review of the literature. J Oral Maxillofac Surg. Jun 2011;69(6):e118-22. [Medline].

  2. Kara M, Akyüz M, Yilmaz A, Hatipoglu C, Ozçakar L. Peripheral nerve involvement in a neurofibromatosis type 2 patient with plexiform neurofibroma of the cauda equina: a sonographic vignette. Arch Phys Med Rehabil. Sep 2011;92(9):1511-4. [Medline].

  3. Huntley JS, Davie RM, Hooper G. A subungual schwannoma. Plast Reconstr Surg. Feb 2006;117(2):712-3. [Medline].

  4. Murakami Y, Wataya-Kaneda M, Tanaka M, Myoui A, Sakata Y, Katayama I. Case of schwannomatosis. J Dermatol. Sep 2009;36(9):508-11. [Medline].

  5. Plaut J, Galloway M, Childerhouse A, Bradford R. Schwannoma with monoclonal plasma cell infiltration. J Neurosurg. Sep 2009;111(3):509-11. [Medline].

  6. Grant DG, Breitenfeldt N, Shepherd NA, Thomas DM. Intranodal neurilemmoma presenting as parotid mass. J Laryngol Otol. Aug 2009;123(8):912-4. [Medline].

  7. Denayer E, Brems H, de Cock P, et al. Pathogenesis of vestibular schwannoma in ring chromosome 22. BMC Med Genet. Sep 22 2009;10:97. [Medline].

  8. Sainz J, Huynh DP, Figueroa K, Ragge NK, Baser ME, Pulst SM. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum Mol Genet. Jun 1994;3(6):885-91. [Medline].

  9. Sainz J, Huynh DP, Figueroa K, Ragge NK, Baser ME, Pulst SM. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum Mol Genet. Jun 1994;3(6):885-91. [Medline].

  10. Geddes JF, Sutcliffe JC, King TT. Mixed cranial nerve tumors in neurofibromatosis type 2. Clin Neuropathol. Nov-Dec 1995;14(6):310-3. [Medline].

  11. Manor E, Tetro S, Noyhous M, Kachko P, Bodner L. Translocation (2;13) and other chromosome abnormalities in intraosseous schwannoma of the mandible. Cancer Genet Cytogenet. Sep 2009;193(2):116-8. [Medline].

  12. Fanburg-Smith JC, Majidi M, Miettinen M. Keratin expression in schwannoma; a study of 115 retroperitoneal and 22 peripheral schwannomas. Mod Pathol. Jan 2006;19(1):115-21. [Medline].

  13. [Guideline] International RadioSurgery Association (IRSA). Stereotactic radiosurgery for patients with vestibular schwannomas. National Guideline Clearinghouse. May 2006.

  14. Peltier J, Page C, Toussaint P, Bruniau A, Desenclos C, Le Gars D. Melanocytic schwannomas. Report of three cases. Neurochirurgie. Sep 2005;51(3-4 Pt 1):183-9. [Medline].

  15. Hayashi K, Hoshida Y, Horie Y, et al. Immunohistochemical study on the distribution of alpha and beta subunits of S-100 protein in brain tumors. Acta Neuropathol. 1991;81(6):657-63. [Medline].

  16. Kao GF, Laskin WB, Olsen TG. Solitary cutaneous plexiform neurilemmoma (schwannoma): a clinicopathologic, immunohistochemical, and ultrastructural study of 11 cases. Mod Pathol. Jan 1989;2(1):20-6. [Medline].

  17. McKeever PE. Immunohistochemistry of the nervous system. In: Dabbs D, ed. Diagnostic Immunohistochemistry. Philadelphia, Pa: Churchill Livingstone Elsevier; 2006:794-5.

  18. McKeever PE. Immunohistochemistry of the nervous system. In: Dabbs D, ed. Diagnostic Immunohistochemistry. Philadelphia, Pa: Churchill Livingstone; 2002:559-624.

  19. McKeever PE. New methods in brain tumor analysis. In: Mena H, Sandberg G, eds. Dr. Kenneth M. Earle Memorial Neuropathology Review. Washington, DC: Armed Forces Institute of Pathology; 2004.

  20. McKeever PE. Laboratory methods in brain tumor diagnosis. In: Nelson JS, Mena H, Parisi, et al, eds. Principles and Practice of Neuropathology. 2nd ed. New York, NY: Oxford University Press; 2003:272-97.

  21. McKeever PE, Boyer P. The brain, spinal cord, and meninges. In: Mills SE, Carter D, Greeson JK, et al, eds. Sternberg's Diagnostic Surgical Pathology. 4th ed. Philadelphia, Pa: Lippincott, Williams & Wilkins; 2004:400-500.

  22. Meis-Kindblom JM, Enzinger FM. Plexiform malignant peripheral nerve sheath tumor of infancy and childhood. Am J Surg Pathol. May 1994;18(5):479-85. [Medline].

  23. Reith JD, Goldblum JR. Multiple cutaneous plexiform schwannomas. Report of a case and review of the literature with particular reference to the association with types 1 and 2 neurofibromatosis and schwannomatosis. Arch Pathol Lab Med. Apr 1996;120(4):399-401. [Medline].

  24. Scheithauer BW, Woodruff JM, Erlandson RA. Tumors of the peripheral nervous system. In: Atlas of Tumor Pathology. 3rd series, Fasc 24. Washington, DC: Armed Forces Institute of Pathology; 1999:105-76.

Previous
Next
 
A schematic illustration of the essential microscopic features of a neurilemoma (schwannoma). A solid lesion arises within a nerve composed of a single fascicle (top). The tumor is composed of Schwann cell proliferation within the epineurium and peripherally displaced nerve fibers, resulting in nodular eccentric growth (middle). No capsule is formed in the early growth phase. The larger tumor (bottom) slightly increases the size of the parent nerve and eventually becomes separated from surrounding fascicles by a capsule formed from the perineurium and epineurium. Occasional axons are present.
A small, clinically freely movable neurilemoma found in the subcutaneous tissue. Note the pale-yellow, somewhat-translucent cut surface. The tumor also exhibits a slight nodular growth pattern on the cut surface. Courtesy of the Atlas of Tumor Pathology Armed Forces Institute of Pathology Fascicles, Tumors of the Peripheral Nervous System. Used with permission.
A larger neurilemoma (5 cm in diameter) arising from a peripheral nerve showing irregularly lobulated and secondary degenerative changes, ie, partly cystic with calcification (the so-called ancient change). Hemorrhage and opaque creamy-yellow areas of tumor are also seen on this cut surface.
Cut surface of an intradermal plexiform (nodular) variety of neurilemoma. The plexiform variants of neurilemoma are rare. The area of nodularity is clearly discernible. Courtesy of the Atlas of Tumor Pathology Armed Forces Institute of Pathology Fascicles, Tumors of the Peripheral Nervous System. Used with permission
A low-power photomicrograph of a dermal plexiform neurilemoma showing nodular aggregates of tumor cells and surrounding loose, myxomatous fibrous stroma. Hematoxylin and eosin stain at 50X magnification.
Photomicrograph of a neurilemoma from an area with a typical Antoni type A pattern. The palisaded benign Schwann cells show nuclear crowding, with cell processes radiating toward the centers of aggregated tumor cells. Inconspicuous loose fibrous stroma is present at the periphery. Hematoxylin and eosin stain at 150X magnification.
A photomicrograph showing a characteristic Verocay body of a neurilemoma, consisting of tight, discrete aggregates of spindle-shaped, palisaded nuclei with a central fibrillary area, representing collections of cytoplasmic processes of tumorous Schwann cells. Courtesy of the Atlas of Tumor Pathology Armed Forces Institute of Pathology Fascicles, Tumors of the Peripheral Nervous System. Used with permission.
Transmission electron micrograph of Antoni type A tumor tissue consisting of prominent arrays of Schwann cell processes with basement membrane substance coated on their surfaces. Note the centrally located nucleus with vesicular nuclear chromatin. Uranium acetate and lead citrate stain at 15,000X magnification.
A transmission electron micrograph of a Luse body, ie, typical collagen fibrils and adjacent basement substance. Note the long-spaced, 130-nm periodicity. Uranium acetate and lead citrate stain at 52,500X magnification. Courtesy of the Atlas of Tumor Pathology Armed Forces Institute of Pathology Fascicles, Tumors of the Peripheral Nervous System. Used with permission.
A photomicrograph of a dermal neurilemoma with anti–S-100 protein immunostaining. The tumorous Schwann cells exhibit uniformly positive staining. Immunoperoxidase stain at 150X magnification.
Solitary cutaneous plexiform neurilemoma shown on photomicrograph.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.